Glecaprevir

Last Updated: 04/28/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 288 publications

Phospholipid-driven conformational switching of HCV NS5A links protein folding to replication membrane remodeling.

Phospholipid-driven conformational switching of HCV NS5A links protein folding to replication membrane remodeling.

Journal: Science advances

Published: April 03, 2026

Antiviral treatment for chronic viral hepatitis B and C in children in Ostrava

Antiviral treatment for chronic viral hepatitis B and C in children in Ostrava

Journal: Klinicka mikrobiologie a infekcni lekarstvi

Published: February 24, 2026

Glecaprevir/Pibrentasvir for Post Traumatic Stress Disorder.

Glecaprevir/Pibrentasvir for Post Traumatic Stress Disorder.

Journal: Psychopharmacology bulletin

Published: January 14, 2026

Recently acquired hepatitis C virus infection in people with HIV - what have we learned?

Recently acquired hepatitis C virus infection in people with HIV - what have we learned?

Journal: Current opinion in HIV and AIDS

Published: November 28, 2025

Successful Retreatment of Chronic Hepatitis C Virus Genotype 1A Infection With Glecaprevir/Pibrentasvir in a Pediatric Patient With Developmental Disorder.

Successful Retreatment of Chronic Hepatitis C Virus Genotype 1A Infection With Glecaprevir/Pibrentasvir in a Pediatric Patient With Developmental Disorder.

Journal: In vivo (Athens, Greece)

Published: November 21, 2025

LIPA-driven reprogramming of tumor-associated macrophages shapes an immunosuppressive microenvironment in osteosarcoma.

LIPA-driven reprogramming of tumor-associated macrophages shapes an immunosuppressive microenvironment in osteosarcoma.

Journal: International immunopharmacology

Published: November 11, 2025

Efficacy and Safety of Glecaprevir/Pibrentasvir in Participants with Chronic HCV Infection and Comorbidities or Multiple Concomitant Medications: An Integrated Analysis.

Efficacy and Safety of Glecaprevir/Pibrentasvir in Participants with Chronic HCV Infection and Comorbidities or Multiple Concomitant Medications: An Integrated Analysis.

Journal: Infectious diseases and therapy

Published: November 06, 2025

Nummular Eczema as the Initial Extrahepatic Manifestation of Hepatitis C Virus Infection: A Case Report.

Nummular Eczema as the Initial Extrahepatic Manifestation of Hepatitis C Virus Infection: A Case Report.

Journal: Cureus

Published: August 04, 2025

Injecting Drug Use History and Younger Age Worsen Adherence to Scheduled Hospital Visits in Glecaprevir and Pibrentasvir Therapy for Chronic Hepatitis C.

Injecting Drug Use History and Younger Age Worsen Adherence to Scheduled Hospital Visits in Glecaprevir and Pibrentasvir Therapy for Chronic Hepatitis C.

Journal: International journal of hepatology

Published: July 17, 2025

Efficacy and Safety of Glecaprevir/Pibrentasvir in Children Aged 3-11 Years With Chronic Hepatitis C: A Real-World, Prospective, Multicenter Study in Japan.

Efficacy and Safety of Glecaprevir/Pibrentasvir in Children Aged 3-11 Years With Chronic Hepatitis C: A Real-World, Prospective, Multicenter Study in Japan.

Journal: Hepatology research : the official journal of the Japan Society of Hepatology

Published: June 12, 2025

A Case Report of Direct-Acting Antiviral Therapy for Chronic Hepatitis C in a Patient With Dementia Treated in Collaboration With Multiple Specialists.

A Case Report of Direct-Acting Antiviral Therapy for Chronic Hepatitis C in a Patient With Dementia Treated in Collaboration With Multiple Specialists.

Journal: Case reports in hepatology

Published: June 04, 2025

A single-arm phase IIIb study of 8-week glecaprevir/pibrentasvir treatment in adults with acute hepatitis C.

A single-arm phase IIIb study of 8-week glecaprevir/pibrentasvir treatment in adults with acute hepatitis C.

Journal: Journal of hepatology

Published: May 16, 2025

Showing 1-12 of 288

Last Updated: 04/28/2026